Ilyang Pharmaceutical Co.,Ltd (KRX:007570)
South Korea flag South Korea · Delayed Price · Currency is KRW
13,050
+10 (0.08%)
Sep 12, 2025, 7:48 AM KST

KRX:007570 Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
233,921205,533281,258349,981510,6551,197,901
Market Cap Growth
-14.71%-26.92%-19.64%-31.46%-57.37%191.80%
Enterprise Value
344,573341,070394,941436,337605,3601,322,774
Last Close Price
12895.0011274.4815257.9318681.4826877.8062597.47
PE Ratio
14.7221.04-18.4936.39110.11
Forward PE
-49.9049.9049.9049.9049.90
PS Ratio
0.850.761.061.412.113.49
PB Ratio
0.940.851.221.472.254.89
P/TBV Ratio
0.970.881.261.512.325.92
P/FCF Ratio
--32.19180.6213.0725.32
P/OCF Ratio
17.4236.6019.2459.499.9320.84
EV/Sales Ratio
1.251.271.481.762.503.85
EV/EBITDA Ratio
19.6016.3813.9316.7722.9228.29
EV/EBIT Ratio
38.3531.0124.1130.6239.8638.79
EV/FCF Ratio
-47.13-45.21225.1915.5027.96
Debt / Equity Ratio
0.480.450.320.310.430.42
Debt / EBITDA Ratio
7.265.172.562.853.732.20
Debt / FCF Ratio
--8.3238.242.522.18
Net Debt / Equity Ratio
0.420.390.260.260.240.25
Net Debt / EBITDA Ratio
6.264.562.082.362.081.31
Net Debt / FCF Ratio
-14.09-2.916.7531.751.411.30
Asset Turnover
0.560.650.670.600.560.78
Inventory Turnover
2.122.792.963.463.403.17
Quick Ratio
0.430.390.470.460.590.60
Current Ratio
0.920.800.890.820.810.92
Return on Equity (ROE)
6.37%4.45%-0.87%8.53%6.25%9.21%
Return on Assets (ROA)
1.00%1.67%2.57%2.17%2.21%4.86%
Return on Invested Capital (ROIC)
1.89%3.01%5.56%4.07%3.45%8.32%
Return on Capital Employed (ROCE)
2.70%4.00%6.50%5.50%6.00%13.00%
Earnings Yield
6.67%4.99%-0.86%5.54%2.75%0.91%
FCF Yield
-3.13%-15.85%3.11%0.55%7.65%3.95%
Dividend Yield
1.15%1.33%0.98%---
Payout Ratio
17.56%29.00%-20.34%16.74%45.05%
Buyback Yield / Dilution
4.07%0.26%0.59%0.44%--
Total Shareholder Return
5.22%1.59%1.57%0.44%--
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.